WASHINGTON/ DETROIT, June 2- Takata Corp will "rapidly" reduce production of a volatile chemical that has been linked to ruptured air bag inflators, a company executive told U.S. lawmakers on Tuesday. The chemical, ammonium nitrate, "appears to be one of the factors" contributing to inflator ruptures linked to six deaths and hundreds of injuries, Kevin Kennedy,...» Read More
India's low-cost mission to Mars successfully entered the orbit, crowning India as the first country to complete the trip at its maiden attempt.
The FDA authorized Tekmira's ebola drug for potential use through an expanded access program. CNBC's Meg Tirrell reports which other companies are working on drugs to fight ebola.
CNBC's Meg Tirell reports the latest projections on the Ebola virus.
The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.
World carbon dioxide emissions will hit a record high this year, driven by China's growth and keeping the world far off track from the deep cuts needed to limit climate change, a study said on Sunday.
Derek Herrera, wounded U.S. Marine Captain, discusses how ReWalk's wearable robotic exoskeleton device has impacted his life for the better and demonstrates the device.
ReWalk CEO Larry Jasinski discusses just how big the market for wearable robotic exoskeleton devices could get.
Unlike a hurricane, tornado or snowstorm, the ends and beginning of droughts are very hard to predict.
CNBC's Meg Tirrell runs down today's top health care headlines, including a major move by President Obama to fight the Ebola virus and the latest on Enterovirus D68.
Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.
"Big Bang" actress Mayim Bialik is a self-proclaimed science geek (she has a Ph.D.) and wants to get kids excited about math and science.
CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
Discussing the new ways to monitor glucose for people with diabetes, and competition in the space, with Terry Gregg, DexCom CEO. Gregg says his business is in conversations with Apple and Samsung in regards to partnering on wearables.
CNBC's Meg Tirrell reports an American missionary doctor serving in Liberia has tested positive for Ebola.
Two major tech investors have plowed $1.5 million into Helion Energy to help it develop a technology that hasn’t worked, according to Oilprice.com.
GlaxoSmithKline is to begin human testing of an experimental Ebola vaccine. CNBC's Meg Tirrell reports the World Health Organization has released a response roadmap with the goal of stopping the spread of Ebola in 6 to 9 months.
Kite Pharma is working on a treatment which involves taking a cancer patient's own t-cells out of their body, genetically modifying them to better target cancer, and then re-administering them. Its CEO Arie Belldegrun, provides insight to the positive study with the therapy.
CNBC's Meg Tirrell breaks down the mega deal between Swiss pharmaceutical firm Roche and InterMune for $8.3 billion.
CNBC's Meg Tirrell speaks to Roche CEO Severin Schwan, and InterMune CEO Daniel Welch, about Roche's $8.3 billion acquisition of InterMune and the opportunity for the drug Esbriet in the U.S.
California's mountains have risen more than half an inch, thanks to the absence of water to weigh them down, a study found. NBC News reports.